At CES 2025, L’Oréal Groupe unveiled L’Oréal Cell BioPrint, an innovative tabletop device that provides a personalized skin analysis in just five minutes. Using cutting-edge proteomics—the study of proteins’ role in skin aging—this technology helps consumers understand their skin’s aging trajectory and the skincare best suited for their needs.
This breakthrough is made possible by L’Oréal’s Longevity Integrative Scienceä and its partnership with Korean startup NanoEnTek. The device offers a detailed, real-time assessment of:
– Skin’s Biological Age: Calculates the skin’s aging speed and offers strategies to slow down visible aging.
– Ingredient Responsiveness: Predicts how well key ingredients, such as retinol, will work for an individual’s skin.
– Proactive Skincare: Identifies predispositions to cosmetic issues like dark spots or enlarged pores before they appear, enabling preemptive care.
Barbara Lavernos, Deputy CEO of Research, Innovation, and Technology at L’Oréal Groupe, said:
“With skin being the largest organ and central to overall well-being, we are thrilled to launch Cell BioPrint. Combining microfluidic lab-on-a-chip technology with our expertise in skin science, we empower individuals with deeper insights about their skin and its longevity.”
Addressing Consumer Demand for Personalization
With the global skincare market projected to reach $125 billion by 2024, consumers increasingly seek personalized and effective solutions. A recent U.S. survey revealed that 80% of skincare users rely on trial and error, testing an average of seven cleansers before finding one they love.
L’Oréal’s Advanced Research team has identified unique biomarkers in the skin that reflect key factors of health and longevity. The device uses NanoEntek’s microfluidic technology, backed by over 100 patents, to analyze protein biomarkers within five minutes.
How It Works:
1. Apply a facial tape strip to the cheek and place it in a buffer solution.
2. Insert the solution into the Cell BioPrint cartridge for analysis.
3. While processing, the Skin Connect device captures facial images and collects answers to a short questionnaire on skin concerns.
Future Rollout
L’Oréal Cell BioPrint will pilot with a L’Oréal brand in Asia in late 2025.
This revolutionary approach transforms skincare from reactive to proactive, empowering consumers to protect and enhance their skin’s longevity and beauty.
